Back
Compass Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
56
CMPX
Compass Therapeutics
Last Price:
$2.64
Seasonality Move:
3.56%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CMPX is experiencing slight buying pressure.
Compass Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.68 | Buy |
| 20-day SMA: | 2.55 | Buy |
| 50-day SMA: | 2.26 | Buy |
| 200-day SMA: | 2.12 | Buy |
| 8-day EMA: | 1.46 | Buy |
| 20-day EMA: | 0.71 | Buy |
| 50-day EMA: | 0.31 | Buy |
| 200-day EMA: | 0.08 | Buy |
Compass Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.52 | Buy |
| Relative Strength Index (14 RSI): | 67.54 | Buy |
| Chaikin Money Flow: | 482967 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.37 - 2.69) | Buy |
| Bollinger Bands (100): | (1.84 - 2.7) | Buy |
Compass Therapeutics Technical Analysis
| Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Compass Therapeutics Stock
Is Compass Therapeutics Stock a Buy?
-
Compass Therapeutics share price is 2.85 while CMPX 8-day simple moving average is 2.68, which is a Buy signal.
-
The stock price of CMPX is 2.85 while Compass Therapeutics 20-day SMA is 2.55, which makes it a Buy.
-
Compass Therapeutics 50-day simple moving average is 2.26 while CMPX share price is 2.85, making it a Buy technically.
-
CMPX stock price is 2.85 and Compass Therapeutics 200-day simple moving average is 2.12, creating a Buy signal.
CMPX Technical Analysis vs Fundamental Analysis
Buy
56
Compass Therapeutics (CMPX)
is a Buy
Is Compass Therapeutics a Buy or a Sell?
-
Compass Therapeutics stock is rated a BuyThe current Compass Therapeutics [CMPX] share price is $2.85. The Score for CMPX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Compass Therapeutics Stock Info
Market Cap:
394.1M
Price in USD:
2.85
Share Volume:
905.6K
Compass Therapeutics 52-Week Range
52-Week High:
4.08
52-Week Low:
0.87
Buy
56
Compass Therapeutics (CMPX)
is a Buy
Compass Therapeutics Share Price Forecast
-
What is the Compass Therapeutics stock price today?The Compass Therapeutics stock price is 2.85 USD today.
-
Will CMPX stock go up or go down?Compass Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Compass Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Compass Therapeutics is not overvalued.
Is Compass Therapeutics Stock a Buy?
-
Compass Therapeutics share price is 2.85 while CMPX 8-day exponential moving average is 1.46, which is a Buy signal.
-
The stock price of CMPX is 2.85 while Compass Therapeutics 20-day EMA is 0.71, which makes it a Buy.
-
Compass Therapeutics 50-day exponential moving average is 0.31 while CMPX share price is 2.85, making it a Buy technically.
-
CMPX stock price is 2.85 and Compass Therapeutics 200-day simple moving average is 0.08, creating a Buy signal.
Fundamental Analysis of Compass Therapeutics
Is Compass Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.15 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Compass Therapeutics
Should I short Compass Therapeutics stock?
-
CMPX Moving Average Covergence Divergence (MACD) indicator is 0.52, suggesting Compass Therapeutics is a Buy
-
Compass Therapeutics Relative Strength Index (RSI) is 67.54, which suggest Compass Therapeutics is overbought
-
The Bollinger Bands (25) for Compass Therapeutics is (2.37 - 2.69), which suggest Compass Therapeutics is a Buy
-
The Bollinger Bands (100) for Compass Therapeutics is (1.84 - 2.7), which suggest Compass Therapeutics is a Buy
* Compass Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.